THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 96 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $670,853 | -16.6% | 77,735 | 0.0% | 0.00% | – |
Q2 2023 | $804,557 | -4.6% | 77,735 | 0.0% | 0.00% | – |
Q1 2023 | $843,425 | -3.3% | 77,735 | 0.0% | 0.00% | – |
Q4 2022 | $872,187 | +10.7% | 77,735 | 0.0% | 0.00% | – |
Q3 2022 | $788,000 | +11.9% | 77,735 | 0.0% | 0.00% | – |
Q2 2022 | $704,000 | -5.2% | 77,735 | 0.0% | 0.00% | – |
Q1 2022 | $743,000 | -13.3% | 77,735 | +0.3% | 0.00% | – |
Q4 2021 | $857,000 | +63.9% | 77,535 | +9.6% | 0.00% | – |
Q3 2021 | $523,000 | -49.1% | 70,735 | 0.0% | 0.00% | – |
Q2 2021 | $1,027,000 | -28.9% | 70,735 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $1,444,000 | +5.9% | 70,735 | -7.8% | 0.00% | 0.0% |
Q4 2020 | $1,364,000 | +20.2% | 76,735 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,135,000 | -30.7% | 76,735 | -1.7% | 0.00% | 0.0% |
Q2 2020 | $1,638,000 | +9.9% | 78,035 | +20.9% | 0.00% | 0.0% |
Q1 2020 | $1,491,000 | -10.3% | 64,535 | +0.5% | 0.00% | 0.0% |
Q4 2019 | $1,663,000 | +35.6% | 64,235 | +2.1% | 0.00% | 0.0% |
Q3 2019 | $1,226,000 | +19.3% | 62,935 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $1,028,000 | -28.0% | 62,935 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $1,427,000 | -11.4% | 62,935 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $1,611,000 | -22.5% | 62,935 | -1.1% | 0.00% | 0.0% |
Q3 2018 | $2,079,000 | +48.3% | 63,635 | +2.9% | 0.00% | 0.0% |
Q2 2018 | $1,402,000 | -3.0% | 61,835 | +3.7% | 0.00% | 0.0% |
Q1 2018 | $1,446,000 | -15.3% | 59,635 | -2.6% | 0.00% | 0.0% |
Q4 2017 | $1,708,000 | -18.6% | 61,235 | 0.0% | 0.00% | -50.0% |
Q3 2017 | $2,097,000 | -14.1% | 61,235 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $2,440,000 | +18.0% | 61,235 | +9.1% | 0.00% | 0.0% |
Q1 2017 | $2,067,000 | +13.3% | 56,135 | -1.9% | 0.00% | 0.0% |
Q4 2016 | $1,825,000 | -12.0% | 57,235 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $2,074,000 | +58.1% | 57,235 | -1.0% | 0.00% | +100.0% |
Q2 2016 | $1,312,000 | +113.3% | 57,839 | +76.7% | 0.00% | 0.0% |
Q1 2016 | $615,000 | +23.2% | 32,739 | +7.6% | 0.00% | – |
Q4 2015 | $499,000 | +49.0% | 30,439 | 0.0% | 0.00% | – |
Q3 2015 | $335,000 | -91.2% | 30,439 | -89.6% | 0.00% | -100.0% |
Q2 2015 | $3,812,000 | +21.6% | 292,777 | +62.0% | 0.00% | 0.0% |
Q1 2015 | $3,135,000 | +111.8% | 180,697 | +82.2% | 0.00% | +200.0% |
Q4 2014 | $1,480,000 | +13.4% | 99,170 | +75.2% | 0.00% | 0.0% |
Q3 2014 | $1,305,000 | -27.7% | 56,611 | -0.0% | 0.00% | -50.0% |
Q2 2014 | $1,805,000 | – | 56,634 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chescapmanager LLC | 1,134,718 | $23,160,000 | 2.47% |
Baupost Group | 8,735,168 | $178,285,000 | 1.42% |
Orbimed Advisors | 6,219,110 | $126,932,000 | 1.19% |
CM Management, LLC | 50,000 | $1,021,000 | 0.76% |
Tekla Capital Management LLC | 456,296 | $9,313,000 | 0.32% |
Rock Springs Capital Management LP | 682,600 | $13,932,000 | 0.30% |
Virtus ETF Advisers LLC | 32,871 | $671,000 | 0.28% |
Cormorant Asset Management, LP | 550,000 | $11,226,000 | 0.25% |
DAFNA Capital Management LLC | 41,165 | $840,000 | 0.20% |
PEREGRINE CAPITAL MANAGEMENT LLC | 484,206 | $9,883,000 | 0.18% |